Zobrazeno 1 - 10
of 920
pro vyhledávání: '"H, Schaller"'
Autor:
Andrew L Mammen, Jarushka Naidoo, Divyanshu Dubey, Michael Dougan, Teilo H Schaller, Meghan J Mooradian, Douglas B Johnson, Jorg Dietrich, Leyre Zubiri, Tomas G Neilan, Bianca D Santomasso, Ryan J Sullivan, Kerry L Reynolds, Allison Betof Warner, Justine V Cohen, Nancy Wang, Jenny Linnoila, Jeffrey M Gelfand, Anthony A Amato, Stacey L Clardy, David A Reardon, William C Louv, Amanda C Guidon, Leeann B Burton, Bart K Chwalisz, James Hillis, Priscilla K Brastianos, Tracey A Cho, Christopher T Doughty, Jeffrey T Guptill, Vern C Juel, Robert Kadish, Noah Kolb, Nicole R LeBoeuf, Maria Martinez-Lage, Krista M Rubin, Karin Woodman
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 7 (2021)
Expanding the US Food and Drug Administration–approved indications for immune checkpoint inhibitors in patients with cancer has resulted in therapeutic success and immune-related adverse events (irAEs). Neurologic irAEs (irAE-Ns) have an incidence
Externí odkaz:
https://doaj.org/article/a2206707f599451b8603379684ad2015
Publikováno v:
Biologia Plantarum, Vol 63, Iss 1, Pp 59-69 (2019)
A unique structural feature of plant sterols is the presence of a 24-alkyl group in the sterol side chain, which is synthesized by C24-sterol methyltransferase (SMT). Here we report for the first time that the bread wheat genome (AABBDD) contains at
Externí odkaz:
https://doaj.org/article/409421bb624f4894912150585a767120
Autor:
Shawn M. Sweeney, Hisham K. Hamadeh, Natalie Abrams, Stacey J. Adam, Sara Brenner, Dana E. Connors, Gerard J. Davis, Louis D. Fiore, Susan H. Gawel, Robert L. Grossman, Sean E. Hanlon, Karl Hsu, Gary J. Kelloff, Ilan R. Kirsch, Bill Louv, Deven McGraw, Frank Meng, Daniel Milgram, Robert S. Miller, Emily Morgan, Lata Mukundan, Thomas O'Brien, Paul Robbins, Eric H. Rubin, Wendy S. Rubinstein, Liz Salmi, Teilo H. Schaller, George Shi, Caroline C. Sigman, Sudhir Srivastava
Publikováno v:
Cancer Research. 83:1183-1190
The analysis of big healthcare data has enormous potential as a tool for advancing oncology drug development and patient treatment, particularly in the context of precision medicine. However, there are challenges in organizing, sharing, integrating,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9042c740550e4c3e4949faea3069c247
https://doi.org/10.1158/0008-5472.can-22-1277
https://doi.org/10.1158/0008-5472.can-22-1277
Autor:
Patrick C Gedeon, Michael A Streicker, Teilo H Schaller, Gary E Archer, Micheal P Jokinen, John H Sampson
Publikováno v:
PLoS ONE, Vol 15, Iss 7, p e0236374 (2020)
We recently reported the development of a fully-human, CD3-binding bispecific antibody for immunotherapy of malignant glioma. To translate this therapeutic (hEGFRvIII-CD3- bi-scFv) to clinical trials and to help further the translation of other simil
Externí odkaz:
https://doaj.org/article/334a6dbbc0df4031bcd8df6d1e46cc04
Autor:
Teilo H. Schaller, John H. Sampson
Publikováno v:
Expert Review of Vaccines, Vol 16, Iss 1, Pp 27-36 (2017)
Introduction: Glioblastoma is the most common primary brain tumor in adults and prognosis remains poor with a median survival of approximately 15–17 months. This review provides an overview of recent advances in the field of glioblastoma immunother
Externí odkaz:
https://doaj.org/article/74e514cb0d6746b99ef8c7ac18825765
Autor:
John H. Sampson, Darell D. Bigner, Luis Sanchez-Perez, Elizabeth A. Reap, Gary E. Archer, Stephen T. Keir, Roger E. McLendon, James E. Herndon, Patrick N. Healy, Xiuyu Cui, Scott E. Szafranski, Robert J. Schmittling, David J. Snyder, Carter M. Suryadevara, Chien-Tsun Kuan, Bryan D. Choi, Satish K. Chitneni, Teilo H. Schaller, Patrick C. Gedeon
Table S2 - Glioma cell lines and patient derived tumor samples used for study with the number of EGFRvIII receptors per cell, the number of EGFRwt receptors per cell and the proportion of cells expressing EGFRvIII in the given cell line or tumor samp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::044ccc0bbab6f20d0b58d82dddba22dd
https://doi.org/10.1158/1078-0432.22464450.v1
https://doi.org/10.1158/1078-0432.22464450.v1
Autor:
John H. Sampson, Darell D. Bigner, Luis Sanchez-Perez, Elizabeth A. Reap, Gary E. Archer, Stephen T. Keir, Roger E. McLendon, James E. Herndon, Patrick N. Healy, Xiuyu Cui, Scott E. Szafranski, Robert J. Schmittling, David J. Snyder, Carter M. Suryadevara, Chien-Tsun Kuan, Bryan D. Choi, Satish K. Chitneni, Teilo H. Schaller, Patrick C. Gedeon
Purpose: Conventional therapy for malignant glioma fails to specifically target tumor cells. In contrast, substantial evidence indicates that if appropriately redirected, T cells can precisely eradicate tumors. Here we report the rational development
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c540ead1b7766f857bb8730e93a593d
https://doi.org/10.1158/1078-0432.c.6525723.v1
https://doi.org/10.1158/1078-0432.c.6525723.v1
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.